Akebia Therapeutics, Inc. SEC filings AKBA
Akebia Therapeutics, Inc. has 886 filings in SEC EDGAR's recent list, going back to Apr 8, 2011. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Listing notice
|
Oct 23, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 14, 2026 | Oct 7, 2026 |
| S-8 | Employee stock plan registration | Aug 5, 2026 | — |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 17, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Apr 28, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2026 | Mar 27, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Material agreement, New debt, Officer or director change
|
Jan 30, 2026 | Jan 27, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Dec 1, 2025 | Nov 28, 2025 |
| 8-K |
Current report
Material agreement
|
Nov 17, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 28, 2025 | Oct 28, 2025 |
| S-8 | Employee stock plan registration | Aug 7, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 13, 2025 | Jun 10, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Apr 29, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Apr 29, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Mar 20, 2025 | Mar 19, 2025 |
| 424B5 | Prospectus supplement | Mar 20, 2025 | — |
| 424B5 | Prospectus supplement | Mar 19, 2025 | — |
| 10-K | Annual report | Mar 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Feb 7, 2025 | Feb 3, 2025 |
| S-8 | Employee stock plan registration | Jan 30, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 22, 2024 | Oct 22, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 16, 2024 | Oct 15, 2024 |
| EFFECT | Filing | Sep 12, 2024 | — |
| CORRESP | Letter to the SEC | Sep 10, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2024 | — |
| S-3 | Shelf registration | Sep 3, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jul 11, 2024 | Jul 10, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 24, 2024 | Jun 21, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 6, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Apr 25, 2024 |
| 8-K |
Current report
New debt
|
Apr 23, 2024 | Apr 17, 2024 |
| 8-K |
Current report
Material agreement
|
Apr 16, 2024 | Apr 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 28, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 15, 2024 | Mar 15, 2024 |
| 10-K | Annual report | Mar 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 13, 2024 | Feb 8, 2024 |
| S-8 | Employee stock plan registration | Jan 30, 2024 | — |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
|
Jan 30, 2024 | Jan 29, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Material agreement
|
Dec 18, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Other events
|
Nov 21, 2023 | Nov 21, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Material agreement
|
Nov 2, 2023 | Oct 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 25, 2023 | Oct 25, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 12, 2023 | Oct 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 26, 2023 | Sep 26, 2023 |
| 10-Q | Quarterly report | Aug 28, 2023 | Jun 30, 2023 |
| 10-K/A | Amended annual report | Aug 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 25, 2023 | Aug 25, 2023 |
| 8-K |
Current report
Listing notice
|
Aug 17, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 11, 2023 | Aug 10, 2023 |
| NT 10-Q | Filing | Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 1, 2023 | Jul 26, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 18, 2023 | Jul 18, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 13, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 8, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 7, 2023 | Jun 7, 2023 |
| S-8 | Employee stock plan registration | Jun 6, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 2, 2023 | May 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 31, 2023 | May 26, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 30, 2023 | May 30, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 25, 2023 | May 24, 2023 |
| 8-K |
Current report
Other events
|
May 23, 2023 | May 22, 2023 |
| 8-K |
Current report
Listing notice
|
May 9, 2023 | May 9, 2023 |
| 10-Q | Quarterly report | May 8, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 8, 2023 | May 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 8, 2023 | May 4, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 28, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 28, 2023 | Apr 27, 2023 |
| 8-K |
Current report
Other events
|
Apr 25, 2023 | Apr 25, 2023 |
| DEFA14A | Additional proxy material | Apr 21, 2023 | — |
| DEFA14A | Additional proxy material | Apr 14, 2023 | — |
| DEFA14A | Additional proxy material | Apr 14, 2023 | — |
| DEFA14A | Additional proxy material | Apr 11, 2023 | — |
| 8-K |
Current report
Other events
|
Apr 11, 2023 | Apr 11, 2023 |
| DEFA14A | Additional proxy material | Mar 31, 2023 | — |
| DEFA14A | Additional proxy material | Mar 27, 2023 | — |
| DEFA14A | Additional proxy material | Mar 27, 2023 | — |
| DEFA14A | Additional proxy material | Mar 27, 2023 | — |
| DEFA14A | Additional proxy material | Mar 24, 2023 | — |
| DEFR14A | Filing | Mar 17, 2023 | — |
| 10-K | Annual report | Mar 10, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Material agreement
|
Mar 2, 2023 | Feb 28, 2023 |
| DEF 14A | Proxy statement | Mar 1, 2023 | Apr 11, 2023 |
| 8-K |
Current report
Other events
|
Feb 21, 2023 | Feb 21, 2023 |
| PRE 14A | Preliminary proxy statement | Feb 17, 2023 | Apr 11, 2023 |
| S-8 | Employee stock plan registration | Jan 30, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, Exit or restructuring costs
|
Dec 28, 2022 | Dec 22, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2022 | Dec 14, 2022 |
| CT ORDER | Filing | Dec 13, 2022 | — |
| 8-K |
Current report
Listing notice
|
Nov 10, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Exit or restructuring costs
|
Nov 8, 2022 | Nov 7, 2022 |
| 10-Q | Quarterly report | Nov 3, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| CT ORDER | Filing | Oct 7, 2022 | — |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Material agreement
|
Jul 18, 2022 | Jul 15, 2022 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jun 30, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 10, 2022 | Jun 6, 2022 |
| 8-K |
Current report
Agreement ended, Listing notice
|
May 13, 2022 | May 12, 2022 |
| 10-Q | Quarterly report | May 9, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| EFFECT | Filing | Apr 28, 2022 | — |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 8, 2022 |
| 424B5 | Prospectus supplement | Apr 7, 2022 | — |
| 8-K |
Current report
Material agreement, Other events
|
Apr 7, 2022 | Apr 7, 2022 |
| 424B5 | Prospectus supplement | Apr 7, 2022 | — |
| 8-K |
Current report
Exit or restructuring costs, Other events
|
Apr 7, 2022 | Apr 1, 2022 |
| 8-K |
Current report
Other events
|
Mar 30, 2022 | Mar 30, 2022 |
| CT ORDER | Filing | Mar 18, 2022 | — |
| POS AM | Filing | Mar 1, 2022 | — |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| POSASR | Filing | Mar 1, 2022 | — |
| 8-K |
Current report
Results of operations
|
Mar 1, 2022 | Mar 1, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Feb 22, 2022 | Feb 18, 2022 |
| S-8 | Employee stock plan registration | Jan 28, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Jan 24, 2022 | Jan 19, 2022 |
| CT ORDER | Filing | Dec 30, 2021 | — |
| 8-K/A |
Amended current report
Officer or director change
|
Dec 15, 2021 | Nov 1, 2021 |
| 10-Q | Quarterly report | Nov 4, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Officer or director change
|
Nov 1, 2021 | Nov 1, 2021 |
| 8-K |
Current report
Other events
|
Sep 28, 2021 | Sep 22, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2021 | Sep 9, 2021 |
| 8-K |
Current report
Other events
|
Aug 24, 2021 | Aug 24, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2021 | Jun 2, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 1, 2021 | Jun 1, 2021 |
| 10-Q | Quarterly report | May 10, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| DEFA14A | Additional proxy material | Apr 22, 2021 | — |
| DEF 14A | Proxy statement | Apr 22, 2021 | Jun 2, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 30, 2021 | Mar 30, 2021 |
| S-3ASR | Automatic shelf registration | Feb 25, 2021 | — |
| 10-K | Annual report | Feb 25, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2021 | Feb 25, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 18, 2021 | Feb 16, 2021 |
| 8-K |
Current report
Material agreement
|
Feb 17, 2021 | Feb 10, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 28, 2021 | Jan 26, 2021 |
| S-8 | Employee stock plan registration | Jan 22, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2021 | Jan 12, 2021 |
| 8-K |
Current report
New debt
|
Dec 15, 2020 | Dec 10, 2020 |
| 8-K |
Current report
Material agreement
|
Dec 2, 2020 | Nov 30, 2020 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| CT ORDER | Filing | Sep 25, 2020 | — |
| 8-K |
Current report
Other events
|
Sep 25, 2020 | Sep 24, 2020 |
| 8-K |
Current report
Material agreement
|
Sep 11, 2020 | Sep 4, 2020 |
| 8-K |
Current report
Other events
|
Sep 3, 2020 | Sep 3, 2020 |
| 10-Q | Quarterly report | Aug 10, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2020 | Aug 10, 2020 |
| CT ORDER | Filing | Jul 15, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Jun 18, 2020 | Jun 15, 2020 |
| CT ORDER | Filing | Jun 12, 2020 | — |
| 8-K |
Current report
Change to shareholder rights, Shareholder vote results
|
Jun 9, 2020 | Jun 5, 2020 |
| DEFA14A | Additional proxy material | May 21, 2020 | — |
| 8-K |
Current report
Other events
|
May 12, 2020 | May 11, 2020 |
| 424B5 | Prospectus supplement | May 12, 2020 | — |
| 424B5 | Prospectus supplement | May 11, 2020 | — |
| 10-Q | Quarterly report | May 5, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 5, 2020 | May 5, 2020 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AKBA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1517022
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.